TrialSignal
Clinical trial intelligence report
Study of Bipolar Disorders and Retinal Electrophysiological Markers
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT05161546
Status
TERMINATED
Phase
NA
Sponsor
Centre Psychothérapique de Nancy
Executive brief
Investment-Ready Snapshot
Study of Bipolar Disorders and Retinal Electrophysiological Markers is a NA clinical asset sponsored by Centre Psychothérapique de Nancy in Bipolar Disorder. SEO and diligence focus: EEG and ERG measurements (Retinaute®, BioSerenity), Actigraphy (Motion Watch 8®, CamNtech), Neuropsychological assessments, Optical Coherence Tomography (OCT), endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT05161546
Indication
Bipolar Disorder
Modality
medical device
Target
EEG and ERG measurements (Retinaute®, BioSerenity), Actigraphy (Motion Watch 8®, CamNtech), Neuropsychological assessments, Optical Coherence Tomography (OCT)
Intervention
EEG and ERG measurements (Retinaute®, BioSerenity), Actigraphy (Motion Watch 8®, CamNtech), Neuropsychological assessments, Optical Coherence Tomography (OCT)
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.